SUMMARY The contribution of alterations in renal hemodynamics to the diuretic and natriuretic actions of atrial natriuretic factor (ANT) was studied in chronically instrumented conscious dogs. Injection of ANF-(99-119), 10 /tg/kg, had no effect on mean arterial pressure, heart rate, renal blood flow, or calculated renal vascular resistance; However, it increased urine flow rate (86 ± 20%) and sodium (118 ± 24%) and potassium (35 ± 22%) excretion (p < 0.05). In contrast, ANF-(99-122), 10 /ig/kg, significantly increased renal blood flow (26 ± 4.5%), reduced renal vascular resistance (24 ± 2.9%) and arterial pressure (5.5 ± 1.9%), and markedly increased urine flow rate (198 ± 34%) and sodium (206 ± 32%) and potassium (75 ± 27%) excretion (p < 0. 1 -3 Recent work from a number of laboratories has indicated that the atrial peptides may prove to be part of a unique biological control mechanism crucial in the regulation of blood vol-
A TRIAL natriuritic factor (ANF) is a family of atrial poly peptides isolated from rat atria and purified and sequenced by Currie et al. 1 -2 as well as others. 34 ANF-(99-119) relaxes intestinal but not vascular smooth muscle in vitro; ANF-(99-122) relaxes both intestinal and vascular smooth muscle. 1 -3 Recent work from a number of laboratories has indicated that the atrial peptides may prove to be part of a unique biological control mechanism crucial in the regulation of blood vol-ume, and a defect in the synthesis or release of these peptides may be important in the development of disease states. 6 -7 The atrial peptides were shown to be powerful natriuretic and diuretic hormones when injected into rats 3 -*• 9 -10 and selectively increase renal blood flow.
11
. 12 In the anesthetized dog, the atrial peptides increase renal blood flow on close arterial injection, reduce arterial pressure when injected intravenously, and with either method of delivery, cause a potent diuresis and natriuresis.
144 HYPERTENSION VOL 12, No 2, AUGUST 1988 of ANF renal blood flow actually falls, 16 and that the natriuretic ANF-(99-119) does not increase renal blood flow.
14 These inconsistencies call into question the overall importance of renal vasodilation to the natriuresis and diuresis following ANF administration. The relationship between changes in renal blood flow and renal function induced by ANF may be due to a number of mechanisms, including 1) renal vasodilation, 2) a change in afferent or efferent arteriolar resistance (or both), 3) a redistribution of intrarenal blood flow. One purpose of the present study was to determine the effects of ANF-(99-122) on renal hemodynamics and function in chronically instrumented conscious dogs.
The absence of vascular actions of ANF-(99-l 19) provided an ideal method for determining the contribution of changes in renal hemodynamics to the natriuresis and diuresis in response to ANF. Although in vitro studies have uniformly found that ANF-(99-122) relaxes vascular smooth muscle, recent studies including our own have shown that the renal vasodilation following ANF administration was only transient even if the infusion was maintained for 1 hour. Another goal of our study was to determine the possible role and importance of reflex mechanisms in the control of renal blood flow during ANF administration and therefore, indirectly, in the control of renal function. These studies were conducted in conscious dogs to avoid the effects of anesthesia on vascular smooth muscle, 17 on reflex control, 18 and on ANF-induced blood flow distribution.
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Materials and Methods
Twenty-four female mongrel dogs were instrumented using sterile surgical techniques under sodium pentobarbital anesthesia. A Doppler ultrasonic flow transducer (Parks Electronics, Beaverton, OR, USA) was placed around the left renal artery, and a Tygon catheter (U.S. Stoneware, Akron, OH, USA) was positioned in the abdominal aorta through a midline laparotomy. The animals were allowed 10 days to 2 weeks to recover before experiments were begun. After the initial experiments, eight of the dogs underwent a left-sided thoracotomy, again using pentobarbital anesthesia and sterile surgical techniques to implant Tygon catheters in the left atrial appendage for the injection of 15-/xm radioactive microspheres (3M, Minneapolis, MN, USA). An additional five female dogs were instrumented with Tygon catheters in the ascending aorta and left atrial appendage for the injection of 9-fj.m microspheres (3M). Renal function was not measured in these dogs. These dogs were allowed 10 days to 2 weeks to recover. During the training period, the dogs became accustomed to the placement of a urinary bladder catheter (Foley, 12F) for urine collection.
Arterial pressure was recorded using the implanted catheter attached to a Statham P23Db strain gauge transducer (Hato Rey, Puerto Rico).
Renal blood flow was measured using an ultrasonic flowmeter (Model 806A, Parks Electronics) and the implanted Doppler flow transducer. Phasic arterial pressure and renal blood flow were recorded on magnetic tape (Model 37OOB, Bell and Howell, Saddle Brook, NJ, USA) and played back on a direct writing oscillograph (Model 2800S, Gould-Brush, Saddle Brook, NJ, USA). Mean flow and pressure were derived using 2-Hz filters. Heart rate was calculated using a cardiotachometer (Model 80574, Beckman, Los Angeles, CA, USA) from the pressure-pulse interval. All of these techniques have been used previously.
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From each urine sample, urine volume was measured and the concentration of urine and plasma sodium and potassium assayed using a flame photometer (Model 343, Instrumentation Laboratories, Chicago, IL, USA). Inulin was administered as a loading dose (3 ml/kg), followed by an infusion (2 ml/kg/hr) that lasted for the entire experiment. ANF-(99-122) infusion was begun 1 hour after the inulin loading dose. Plasma and urine samples were taken simultaneously for the analysis of inulin (American Critical Care, Chicago, IL, USA) concentration using a spectrophotometric assay. 22 Hematocrit was also measured in each blood sample. Urine flow rate was calculated based on the volume of urine collected and the collection interval.
Intrarenal blood flow distribution was measured using the radioactive microsphere technique 23 -24 in eight of the dogs. Radioactive microspheres (15 ,m) labeled with cerium-141, strontium-85, and scandium-46 were used. Due to difficulties inherent in measuring intrarenal blood flow with microspheres 23 9 ± 1 fim microspheres (3M) were also used to study renal blood flow in five additional dogs. The order of the isotopes was randomized. A reference arterial blood sample was taken at a fixed rate (10 ml/min) from a femoral arterial catheter, implanted on the day of the experiment using local anesthesia, starting just before the microsphere injection and continuing for 90 seconds. The animal was killed using an overdose of sodium pentobarbital. ANF-(99-122) or ANF-(99-119) was infused at 10 ^.g/kg/min for 4 minutes to achieve steady state changes in renal blood flow to allow use of radioactive microspheres.
The right and left kidneys were removed, weighed, and then sectioned into four cortical zones. Four samples were taken from each zone of the kidney and averaged in each animal. The number of counts in each sample was quantitated using a gamma spectrophotometer (Model 8500, Searle, Chicago, IL, USA) adjusted to separate the isotopes used. Microsphere blood flow was calculated using standard techniques as previously described. 26 Comparisons were made between the right and left kidney (i.e., without and with an implanted flow transducer, respectively) to ensure that placement of the flow transducer did not alter left renal hemodynamics. Polysorbate 80 (Tween 80) was injected into each dog 90 minutes before ANF infusion. 27 All ANF injections or infusions were given intravenously. In five of the dogs plasma ANF levels were measured before and 3, 5, 10, 15, and 20 minutes after the bolus injection of ANF-(99-122) (10 fig/  kg ). Blood samples were taken in EDTA and aprotonin and immediately centrifuged in the cold. Plasma samples were stored at -80 °C. The antibody to ANF-(99-126) (Peninsula Laboratories, Los Angeles, CA, USA) was used following extraction of the plasma using a C-18 column. The percent recovery was calculated for each sample by adding 2000 cpm ANF-(99-126) to the original sample before extraction. ANF-(99-122) cross-reacts 100% with the Peninsula antibody for ANF-(99-126). Plasma ANF-(99-122) concentration was measured by standard radioimmunoassay techniques. 
Effects of ANF Infusion (10 /ig/kg/min) on Renal Hemodynamics and Function and Intrarenal Blood Flow Distribution
In eight of the dogs, ANF-(99-122) was infused at a rate of 10 ^g/kg/min for 4 minutes. Renal blood flow was measured continuously, using the previously implanted Doppler flow transducer, along with arterial pressure, heart rate, and renal function. Radioactive microspheres were injected into the left atrium prior to infusion of ANF-(99-122) and 3 minutes into the infusion, when steady state increases in renal blood flow were measured using the Doppler flowmeter. A third microsphere injection was made 10 minutes after cessation of the ANF-(99-122) infusion, when maximal increases in urine flow rate were achieved. In three separate male dogs, instrumented with left atrial and thoracic aortic Tygon catheters only, ANF-(99-119) was infused at 10 /tg/kg/min for 4 minutes and radioactive microspheres injected as described for ANF-(99-122) to determine the role of intrarenal blood redistribution in the natriuresis and diuresis. Renal function was not measured in these three dogs.
In another five dogs, ANF-(99-122) was infused briefly and 9-fim microspheres used to measure intrarenal blood flow. Renal function and blood flow were not measured in these dogs. These small microspheres were used to avoid overestimation of renal cortical flow as seen with 15-/xm spheres.
Effects of Prolonged ANF Infusion (5 /xg/kg/min) on Renal Blood Flow and Function Before and After a,-Adrenergic Receptor Blockade
In five dogs ANF-(99-122) was infused at a rate of 5 /u.g/kg/min for 1 hour to study changes in glomerular filtration, renal hemodynamics, and renal function. In the same five dogs at least 1 week later, ANF-(99-122) was infused for 1 hour following administration of prazosin (1 mg/kg). Prazosin was administered 40 minutes prior to infusion of ANF-(99-122) as previously described, 28 and a,-adrenergic receptor blockade was ensured by the absence of response to phenylephrine (10 /ng/kg).
Data Collection and Statistical Analysis
Recordings of phasic and mean arterial pressure and renal blood flow and heart rate were made for at least 40 minutes prior to the injection or infusion of ANF. Urine was collected for two 20-minute periods before ANF administration and for twelve 5-minute periods (1 hour) following ANF injection or brief infusion. During 1-hour infusions data were obtained every 10 minutes for measurement of glomerular filtration rate (GFR), sodium, potassium, and hemodynamics. Measurements of renal blood flow, arterial pressure, and heart rate were taken prior to ANF administration and just before each urine collection. All data were stored on a DEC Pro 350 computer (Digital Equipment, Tarrytown, NY, USA). Renal vascular resistance was calculated as the quotient of mean arterial pressure and renal blood flow. GFR was also calculated. Mean and standard errors of the mean were calculated for each collection period. A one-way analysis of variance was used to determine changes that were significantly different from control, 29 and a two-way analysis of variance was used to determine differences between ANF-(99-119) and ANF-(99-122) or before and after a r adrenergic receptor blockade. Values are expressed as the mean ± SEM in the text, tables, and figures. Significant changes (p < 0.05) are denoted.
Results
Effects of ANF-(99-119) and ANF-(99-122) (10 Mg/kg) on Renal Hemodynamics and Function in Conscious Dogs
Whereas ANF-(99-l 19) had no significant effect on mean arterial pressure, renal blood flow (6.3 ± 4.0%), calculated renal vascular resistance, or heart rate, ANF-(99-122) caused a marked initial increase in renal blood flow and fall in renal vascular resistance (Table 1) . Renal blood flow, following injection of ANF-(99-122) increased 26 ± 4.5% from 2% ± 1 9 ml/min and renal vascular resistance fell 24 ± 2.9% from 0.35 ± 0.02 mm Hg/ml/min (p < 0.01).
In spite of the lack of renal hemodynamic effects, ANF-(99-l 19) increased urine flow rate, and sodium and potassium excretion. Hematocrit did not change from 39 ± 1.8%. Plasma sodium did not change from 144 ± 6.3 mEq/L, and plasma potassium did not change from 4.15 ± 0.16 mEq/L.
On the other hand, ANF-(99-122) increased renal blood flow, urine flow rate, and sodium and potas- The time course of changes in renal blood flow, arterial pressure, heart rate, urine flow rate, and sodium and potassium excretion for the first 10 minutes following ANF-(99-122) infusion is similar to that shown for injection in Table 1 . Briefly, ANF-(99-122) infusion increased renal blood flow by 24 ± 2.7% and reduced renal vascular resistance by 24 ± 1.4%. Heart rate increased (18 ± 5.7%), and mean arterial pressure fell (5.1 ± 0.9%). There was a marked increase in urine flow rate (199 ± 25%), sodium excretion (290 ± 82%), and potassium excretion (104 ± 17%). Hematocrit did not change from 36 ± 2.0%. Plasma sodium and potassium did not change from 144 ± 1.0 and 4.16 ± 0.13 mEq/L, respectively.
Radioactive microspheres were injected prior to ANF-(99-122) infusion, during the steady state effects on blood flow, and 10 minutes after stopping the ANF-(99-122) infusion, at a time when urine flow rate was maximal. These data are presented in Table 2 . During the steady state effects of ANF-(99-122), blood flow increased in the outer cortical zones by % ± 25% from 3.37 ± 0.42 ml/min/g in the left and by 76 ± 22% from 3.78 ± 0.61 ml/min/ g in the right kidney, whereas flow did not change in the inner cortical zone (see Table 2 ).
In three dogs, infusion of ANF-(99-119) (10 /xg/ kg/min) had no effect in either the left or right kidney on intrarenal blood flow distribution. For instance, in Zone 1, 2, 3, or 4 of the left kidney, renal blood flow did not change from 3.90 ± 0.71, 3.52 ± 0.35, 2.07 ± 0.17, and 0.85 ± 0.16 ml/min/ g, respectively, during the infusion of ANF-(99-119). Intrarenal blood flow distribution did not vary in these dogs 10 minutes after the infusion of ANF-(99-119). In dogs in which 9-/nm microspheres were used to measure intrarenal blood flow, Values are means ± SEM of eight dogs. There were no significant differences between the right and the left kidney. Steady state values were determined during the ANF infusion (3 minutes) and then 10 minutes after the infusion.
*p < 0.05, compared with control.
outer cortical blood flow increased (Table 3) , as seen with 15-^,m microspheres.
Effects of a 1-Hour Infusion of ANF-(99-122) (5 /xg/kg/min) on Renal Blood Flow and Renal Function
The increase in renal blood flow and fall in renal vascular resistance was only transient and was followed by a reduction in blood flow and increase in renal resistance ( Figure 1 and Table 4 ). Despite the transient renal vasodilation, urine flow rate, GFR, and sodium and potassium excretion remained elevated at 30 minutes (Figure 2) respectively. Hematocrit increased, whereas plasma sodium (145 ± 1 . 5 mEq/ L) and potassium (3.75 ± 1.3 mEq/L) did not change.
Effects of a,-Adrenergic Receptor Blockade on Renal Function and Blood Flow During ANF-(99-122) Infusion
In contrast to the transient renal vasodilation, after a r adrenergic receptor blockade renal blood flow remained elevated for the duration of the ANF-(99-122) infusion. The increase in GFR and urine flow rate developed slowly but increased to the same degree in the presence of a,-adrenergic receptor blockade (see Figure 2 ) as in the unblocked state.
Discussion
ANF-(99-l 19) and ANF-(99-122) both cause natriuresis and diuresis in the conscious dog, whereas only ANF-(99-122) has a significant, although transient, effect on renal blood flow. Injection of equal doses of ANF-(99-119) and ANF-(99-122) caused increases (86 ± 20 and 198 ± 34%) in urine flow rate initially. While ANF-{99-119) had no significant effect on renal blood flow, ANF-(99-122) increased renal blood flow markedly, but only briefly. This increase in renal blood flow was associated with a reduction in renal vascular resistance and an increase in blood flow to the outer cortical zones of the kidney. In the three outer cortical zones, blood flow increased, whereas there was no significant change in blood flow to the inner cortical zone. In contrast, ANF-(99-119) had no effect on intrarenal blood flow distribution.
In further support of the concept of a blood flowindependent mechanism are the data comparing the changes in renal blood flow and renal function 10 minutes after injection of either ANF-(99-l 19) or ANF-(99-122). At that time, neither drug caused a significant increase in renal blood flow; nonetheless, urine flow rate and sodium excretion were 
FIGURE I. Effect of a 60-minute infusion of ANF-(99-122), 5 fJ-g/kg, before (•) and after (A) a,-adrenergic receptor blockade in five dogs. The initial renal vasodilation in response to ANFA99-122) was prolonged following a,-adrenergic receptor blockade, indicating that the secondary vasoconstriction was most likely reflex.
Asterisk indicates significant difference compared with control fp < 0.05). AP = arterial pressure; RBF = renal blood flow; HR = heart rate.
elevated. This response indicates that a net increase in renal blood flow is not entirely responsible for either initiation or maintenance of the natriuresis and diuresis in response to ANF but may simply hasten the onset of the diuresis. These data, including the increase in GFR, 10 -M ' 31 are consistent with constriction of the efferent arteriole for the maintenance of the diuresis in response to either peptide and the early diuresis in response to ANF-(99-119). 32 Similar changes have been reported by others in dogs 16 -33 and in humans. 34 The plasma ANF level following intravenous injection, as measured by our radioimmunoassay, increased to greater than 43,000 pg/ml and returned only to 799 pg/ml after 20 minutes. To date, the maximum plasma peptide level reported in humans is about 800 pg/ml. 35 Thus, the levels achieved in the present study, which caused only transient renal vasodilation, are far in excess of what might occur physiologically. 34 -37 Although my colleagues and I have not studied the effects of the 28 amino acid peptide, ANF-(99-122) and ANF-(99-126) are equally potent in the monkey (unpublished observations; 1986).
Although there was no significant increase in renal blood flow 10 minutes after the infusion of ANF-(99-122), an increase in outer cortical blood flow was seen using the 15-/xm radioactive microspheres. This effect was not observed when small 9-tm microspheres were used and may support the contention that the use of 15-/Am microspheres overestimates renal cortical blood flow. 25 There was no change in intrarenal blood flow distribution during ANF-(99-119) infusion; thus, there was no systematic error in using microspheres.
Our results with 15-/urn microspheres are supported by data with 9-/im spheres; thus, it is unlikely that we overestimated outer cortical blood flow during the initial vasodilation. Radioactive microspheres, as used in our study, do not discriminate between an increase in the number of glomeruli perfused and an increased perfusion of each individual glomerulus. During the initial transient vasodilation the actions of ANF-(99-122) on GFR can be explained by an initial increase in renal blood flow, by an effect on the filtration properties of the glomerulus, and by a possible perfusion of normally unperfused glomeruli in the cortex. Alternatively, an alteration in efferent (constriction) and afferent (vasodilation) arteriolar resistance may occur. However, this occurrence is unlikely during the initial acute renal vasodilation since microspheremeasured blood flow increased and all of the excess blood flow would have to have been filtered. The effects of ANF on renal tubules are more controversial and as yet unsettled 30 -38 ; a direct tubular action could not be defined by our studies.
Our data are supported by a number of studies in dogs, 13 - 39 -41 in which the renal vasodilation during ANF infusion or injection is only transient while the natriuresis and diuresis persist. On the other hand, our data with radioactive microspheres are at odds with an early report by Borenstein et al. 15 In that study an extract of atrial tissue increased inner cortical blood flow, as measured using radioactive microspheres or albumin uptake. 13 These studies reported a 29% increase in inner cortical blood flow, the portion of the kidney that has the lowest baseline blood flow. This increase was accompanied by a reduction in mean arterial pressure from 122 ± 3 to 109 ± 4 mm Hg or 126 ± 2 to 107 ± 4 mm Hg during studies using radioactive microspheres or albumin, respectively. McNay and Abe 42 reported that aortic constriction-induced systemic hypotension caused a shift in renal blood flow to the inner cortex. Perhaps the discrepancy between the study by Borenstein et al. 15 in rats and our study in dogs can be explained by the differences in species used or by the degree of hypotension. One obvious additional difference, however, is that the study by Borenstein et al. 15 was conducted in the anesthetized rat using a crude extract and ours was performed in the conscious dog using a purified peptide. There are species differences, as seen with heart rate regulation; in the rat, for instance, ANF- (99-122) causes bradycardia while in the conscious dog ANF-(99-122) causes mild tachycardia. 43 Finally, it could be argued that radioactive microspheres cannot be used to measure intrarenal blood flow 27 ; however, McNay and Abe 42 went to great extremes in the dog to prove their validity and Borenstein et al., 15 the authors most often quoted in this respect, defended the use of 15 ± 3 fim microspheres, especially within the same animal.
In a recent study using a Doppler lazer technology, Hansell and Ulfendahl 44 have also reported an increase in outer cortical blood flow (22%) following ANF infusion in the rat. These authors reported an increase in inner cortical blood flow (99%) as well as only a 12 mm Hg fall in arterial pressure. Again, the percent increase in inner cortical blood flow was significant; however, the absolute increase in outer cortical blood flow was much greater. As in our study, ANF-(99-119) had no effect on renal blood flow distribution. It is also interesting and consistent with our data that the majority of binding sites for ANF in the kidney are in the glomeruli, which are located predominantly in the cortex, not in the medulla. The exact site of peptide binding-whether on glomerular membranes or glomerular blood vessels-is not known. 43 - 46 Since a number of authors 13 -32 believe that the increase in GFR following ANF injection is due to efferent arteriolar constriction, a significant increase in vasa recta blood flow seems unlikely.
Our data are consistent with the natriuresis and diuresis described by others in the rat 6 Wakitani et al., 12 that at least a portion of the diuresis and natriuresis is blood flow-dependent. This conclusion is further substantiated by the initial increase in perfusion, as measured by radioactive microspheres, in the outer cortex of the kidney and by the transient dramatic increase in renal blood flow during a 1-hour infusion. Prolonged infusion of ANF-(99-122) resulted in sustained increases in renal function despite the Table 4 shows a clear fall in renal vascular resistance after aadrenergic blockade during ANF-(99-122) infusion. Before a-blockade renal resistance did not change, most likely because of the contribution of reflex a-adrenergic constriction and renal autoregulation. After a-adrenergic blockade, a prolonged dilator effect of ANF-(99-122) infusion was uncovered, as shown by significant sustained increases in renal blood flow and a fall in renal vascular resistance. This effect resulted in a more slowly developing natriuresis and diuresis that increased to the same extent from a lower baseline. Although the percent changes in renal function were equal (see Figure 1) , the absolute changes were less following aadrenergic blockade (see Table 4 ). If arblockade eliminates the efferent arteriolar constriction, then it appears that 1) an adrenergic mechanism is responsible for efferent constriction, 2) this constriction enhances GFR and 3) the constriction only promotes the effects of ANF-(99-122) and is not necessary for its actions. In a recent study we found that ANF-(99-122) reduced arterial pressure; this unloaded the systemic arterial baroreceptor reflexes, resulting in tachycardia and positive inotropic action, which were eliminated by autonomic receptor blockade. These effects were accompanied by an increase in stroke volume and cardiac output. 41 The a r adrenergic renal vasoconstriction following ANF-(99-122) may reflect the renal efferent arm of this reflex.
